YouTuber Denys Shvetsov (Rendaros UA) reported announced on its Twitter account that HamUA studio has released a full-fledged Ukrainian localization o ...

The voice behind Team Fortress 2's Sniper, John Lowrie, confirms that they indeed play a character in Valve's new MOBA ...

Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and ...

Positive interim Phase 1 data indicate APG808 was well-tolerated with half-life of approximately 55 days, supporting potential for 2- to 3- month dos ...

ProLynx Inc., a biotechnology company developing proprietary systems to extend the half-life, improve efficacy, and reduce toxicities of important therapies, today announced that research of the ...

Learn more about the metabolic effects of liraglutide treatment in individuals with type 2 diabetes and obesity.

We are pleased to have published results from our Phase 1 MAD study of MBX 2109 in JCEM, a leading peer-reviewed journal of endocrine and metabolic research,” said Kent Hawryluk, President and Chief ...

Researchers at Massachusetts Eye and Ear developed a preclinical research proof of concept that shows mRNA-based therapies ...

Walnut Village, a Front Porch Community in Anaheim, California, announces the Grand Opening of their new, expanded memory care neighborhood. Called Summer House, the neighborhood will provide care for ...

Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate clinically meaningful activity in 2L+ HNSCC – <a targ ...

Hua Medicine (the 'Company', HKEx stock code: 2552) announced today that the Company has successfully completed a Phase I clinical trial on its 2nd generation ...

Week 13 was a weird one for young quarterbacks. Bryce Young and Drake Maye each shined in heartbreaking losses. C.J. Stroud ...